Evidence map›Paper›PMID 36108055›Full record

ArticleCirculation research2022

Functions Beyond the Editor's I in Regulating Cardiac Innate Immunity and Heart Failure.

Jing Zhang, Erika J Gutierrez-Lara, Yan Liang, Farah Sheikh

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Jing Zhang *Department of Medicine (Cardiology Division), University of California San Diego, La Jolla.
Erika J Gutierrez-Lara *Department of Medicine (Cardiology Division), University of California San Diego, La Jolla.
Yan LiangDepartment of Medicine (Cardiology Division), University of California San Diego, La Jolla.
Farah SheikhDepartment of Medicine (Cardiology Division), University of California San Diego, La Jolla.ORCID 0000-0003-2610-0125

Funding

Cardiac Myosin Binding Protein-C in Development and Reversal of Heart FailureR01HL145534 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI TONG, CARL WEI-CHAN · 2019 to 2023
$2.4M
Uncovering Molecular Targets for Arrhythmogenic Cardiomyopathy TherapeuticsR01HL162369 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHEIKH, FARAH · 2022 to 2025
$2.0M
Uncovering New Functions of CSN6 in Cardiac Desmosomal Biology and DiseaseR01HL142251 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHEIKH, FARAH · 2018 to 2021
$1.6M
NHLBI NIH HHS R01 HL142251NHLBI NIH HHS R01 HL145534NHLBI NIH HHS R01 HL162369
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart FailureHeartHumansImmunity, Innateadenosine deaminasecardiac muscleEditorialsheart failureinnate immunityinterferonRNA editing

Identifiers

PMID36108055
PMCPMC10068842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.